Skip to main content

MoneyWorks4Me

Concord Drugs informs about compliance certificate

14 Oct 2025 Evaluate

Concord Drugs has informed that it enclosed the Certificate from Registrar and Share Transfer Agent (R&T Agent) - Aarthi Consultants under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for Concord Drugs for the quarter ended 30th September, 2025.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1886.80
Dr. Reddys Labs. 1386.00
Cipla 1410.00
Lupin 2014.00
Zydus Lifesciences 1205.50
View more..